Antigenics to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
New York-November 3, 2008-Antigenics Inc. (NASDAQ: AGEN) today announced that Garo Armen, Ph.D., the company’s chairman and chief executive officer, will present at the Rodman and Renshaw 10th Annual Healthcare Conference at the Palace Hotel in New York on Monday, November 10, 2008 at 12:25 p.m. Eastern Time.
Dr. Armen will provide an overview of the company and its priority development programs, including Oncophage® (vitespen) therapeutic cancer vaccine and QS-21™ vaccine adjuvant.
The audio portion of the presentation and presentation slides will be webcast live and available by replay on the Rodman & Renshaw website at wsw.com/webcast/rrshq14/agen/. The replay will be available for approximately 90 days. The link to the audio replay and presentation slides will also be available on the Antigenics website, www.antigenics.com.
About Antigenics
Antigenics (NASDAQ: AGEN) is a biotechnology company working to develop treatments for cancers and infectious diseases. The company’s investigational product portfolio includes Oncophage(R), a patient-specific therapeutic cancer vaccine being evaluated in several indications; Aroplatin™ (L-NDDP), a liposomal, third-generation platinum chemotherapeutic; AG-707, a therapeutic vaccine for the treatment of genital herpes; and QS-21 Stimulon®, an adjuvant being evaluated by Antigenics’ collaborative partners in approximately 15 clinical stage vaccines. For more information, please visit www.antigenics.com.
|
